Martin E Cearnal - Net Worth and Insider Trading

Martin E Cearnal Net Worth

The estimated net worth of Martin E Cearnal is at least $209,706 dollars as of 2024-11-13. Martin E Cearnal is the Sr VP/Chief Commercial Officer of Cumberland Pharmaceuticals Inc and owns about 178,473 shares of Cumberland Pharmaceuticals Inc (CPIX) stock worth over $209,706. Details can be seen in Martin E Cearnal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martin E Cearnal has not made any transactions after 2021-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Martin E Cearnal

To

Martin E Cearnal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Martin E Cearnal owns 1 companies in total, including Cumberland Pharmaceuticals Inc (CPIX) .

Click here to see the complete history of Martin E Cearnal’s form 4 insider trades.

Insider Ownership Summary of Martin E Cearnal

Ticker Comapny Transaction Date Type of Owner
CPIX Cumberland Pharmaceuticals Inc 2021-12-20 director

Martin E Cearnal Latest Holdings Summary

Martin E Cearnal currently owns a total of 1 stock. Martin E Cearnal owns 178,473 shares of Cumberland Pharmaceuticals Inc (CPIX) as of December 20, 2021, with a value of $209,706.

Latest Holdings of Martin E Cearnal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPIX Cumberland Pharmaceuticals Inc 2021-12-20 178,473 1.18 209,706

Holding Weightings of Martin E Cearnal


Martin E Cearnal Form 4 Trading Tracker

According to the SEC Form 4 filings, Martin E Cearnal has made a total of 7 transactions in Cumberland Pharmaceuticals Inc (CPIX) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Cumberland Pharmaceuticals Inc is the acquisition of 2,114 shares on December 20, 2021, which cost Martin E Cearnal around $9,576.

Insider Trading History of Martin E Cearnal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Martin E Cearnal Trading Performance

GuruFocus tracks the stock performance after each of Martin E Cearnal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin E Cearnal is 6.31%. GuruFocus also compares Martin E Cearnal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin E Cearnal within 3 months outperforms 3 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Martin E Cearnal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Martin E Cearnal

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -5.58 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.45 LIMIT LIMIT LIMIT LIMIT LIMIT

Martin E Cearnal Ownership Network

Ownership Network List of Martin E Cearnal

No Data

Ownership Network Relation of Martin E Cearnal

Insider Network Chart

Martin E Cearnal Owned Company Details

What does Cumberland Pharmaceuticals Inc do?

Who are the key executives at Cumberland Pharmaceuticals Inc?

Martin E Cearnal is the director of Cumberland Pharmaceuticals Inc. Other key executives at Cumberland Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO A J Kazimi , Vice Pres Sales & Marketing Chris T. Bitterman , and Vice Pres Organizational Dev Todd M. Anthony .

Cumberland Pharmaceuticals Inc (CPIX) Insider Trades Summary

Over the past 18 months, Martin E Cearnal made no insider transaction in Cumberland Pharmaceuticals Inc (CPIX). Other recent insider transactions involving Cumberland Pharmaceuticals Inc (CPIX) include a net purchase of 7,107 shares made by Kenneth Krogulski , a net purchase of 1,426 shares made by James Jones , and a net purchase of 1,426 shares made by A J Kazimi .

In summary, during the past 3 months, insiders sold 0 shares of Cumberland Pharmaceuticals Inc (CPIX) in total and bought 10,672 shares, with a net purchase of 10,672 shares. During the past 18 months, 0 shares of Cumberland Pharmaceuticals Inc (CPIX) were sold and 10,672 shares were bought by its insiders, resulting in a net purchase of 10,672 shares.

Cumberland Pharmaceuticals Inc (CPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cumberland Pharmaceuticals Inc Insider Transactions

No Available Data

Martin E Cearnal Mailing Address

Above is the net worth, insider trading, and ownership report for Martin E Cearnal. You might contact Martin E Cearnal via mailing address: 31 Upper Mountain Avenue, Apartment 2, Montclair Nj 07042.